22q11 deletions and cardiac disease

Progress in Pediatric Cardiology

Volumn 6, Issue 1, 1996, Pages 19-28

  Lewin, Mark B ^a,b   Lindsay, Elizabeth A ^a   Baldini, Antonio ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Aortic arch anomaly; Chromosome 22q11 deletions; Congenital heart disease; Conotruncal cardiac defect; DiGeorge syndrome; Molecular cardiology; Velo cardio facial syndrome

Indexed keywords

AORTA ARCH ANOMALY; CHROMOSOME 22Q; CHROMOSOME DELETION; CONGENITAL HEART DISEASE; DIGEORGE SYNDROME; HEART DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 0030221437     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/1058-9813(96)00168-3     Document Type: Article

References (51)

1. [1] Nora JJ. Causes of CHD: old and new modes, mechanisms and models. Am Heart J 1993;125:1409-1418.
2. [2] Demczuk S, Desmaze C, Aikem M et al. Molecular cytogenetic analysis of a series of 23 DiGeorge syndrome patients by fluorescence in situ hybridization. Ann Genet 1994;37:60-65.
3. [3] Driscoll DA, Budarf ML, Emanuel BS. A genetic etiology for DiGeorge syndrome: consistent deletions and microdeletions of 22q11. Am J Hum Genet 1992;50:924-933.
4. [4] Goldmuntz E, Driscoll D, Budarf ML et al. Microdeletions of chromosomal region 22q11 in patients with congenital conotruncal cardiac defects. J Med Genet 1993;30:807-812.
5. [5] Greenberg F, Elder FFB, Haffner P, Northrup H, Ledbetter DH. Cytogenetic findings in a prospective series of patients with DiGeorge anomaly. Am J Genet 1988;43;605-611.
6. [6] Levy-Mozziconacci A, Ernert F, Scambler P et al. Clinical and molecular study of DiGeorge sequence. Eur J Pediatr 1994;153:813-820.
7. [7] Lindsay EA, Goldberg R, Jurecic V et al. Velo-cardio-facial syndrome: frequency and extent of 22q11 deletions. Am J Med Genet 1995;57:514-522.
8. [8] Lindsay EA, Greenberg F, Shaffer LG, Shapira SK, Scambler PJ, Baldini A. Submicroscopic deletions at 22q11.2: Variability of the clinical picture and delineation of a commonly deleted region. Am J Med Genet 1995;56:191-197.
9. [9] Takahashi K, Kido S, Hoshino K, Ogawa K, Ohashi H, Fukushima Y. Frequency of a 22q11 deletion in patients with conotruncal cardiac malformations: a prospective study. Eur J Pediatr 1995;154:878-881.
10. [10] Wilson DI, Goodship JA, Burn J, Cross IE, Scambler PJ. Deletions within chromosome 22q11 in familial congenital heart disease. Lancet 1992;340:573-575.
11. [11] Wilson DI, Cross IE, Goodship JA et al. A prospective cytogenetic study of 36 cases of DiGeorge syndrome. Am J Hum Genet 1992;51:957-963.
12. [12] Melchionda S, Digilio CD, Mingarelli R et al. Transposition of the great arteries associated with deletion of chromosome 22q11. Am J Cardiol 1995;75:95-98.
13. [13] Momma K, Kondo C, Matsuoka R. Tetralogy of Fallot with pulmonary atresia associated with chromosome 22q11 deletion. J Am Coll Cardiol 1996;27:198-202.
14. [14] Johnson MC, Strauss AW, Dowton SB et al. Deletion within chromosome 22 is common in patients with absent pulmonary valve syndrome. Am J Cardiol 1995;76:66-69.
15. [15] Amati F, Mari A, Digilio MC et al. 22q11 deletions in isolated and syndromic patients with tetralogy of Fallot. Hum Genet 1995;95:479-482.
16. [16] Pierpont MEM, Gobel JW, Moller JH, Edwards JE. Cardiac malformations in relatives of children with truncus arteriosus or interruption of the aortic arch. Am J Cardiol 1988;61:423-427.
17. [17] Augusseau S, Jouk S, Jalbert P, Prieur M. DiGeorge syndrome and 22q11 rearrangements. Hum Genet 1986;74;206-207.
18. [18] Scambler PJ, Kelly D, Lindsay E et al. Velo-cardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus. Lancet 1992;339:1138-1139.
19. [19] Burn J, Takao A, Wilson D et al. Conotruncal anomaly face syndrome is associated with a deletion within chromosome 22q11. J Med Genet 1993;30:822-824.
20. [20] DiGeorge AM. Congenital absence of the thymus and its immunologic consequences: concurrence with congenital hypoparathyroidism, White Plains, New York: March of Dimes-Birth Defects Foundation. Birth Defects 1968;IV:116-121.
21. [21] Clark EB. Mechanisms in the pathogenesis of congenital cardiac malformations. In: Pierpont ME and Moller JM, editors. The Genetics of Cardiovascular Disease. Boston; Martinus-Nijhoff, 1987:3-11.
22. [22] de la Chapelle A, Herva R, Koivisto M, Aulla O. A deletion in chromosome 22 can cause DiGeorge syndrome. Hum Genet 1981;57:253-256.
23. [23] Scambler PJ, Carey AH, Wyse RKH et al. Microdeletions within 22q11 associated with sporadic and familial DiGeorge syndrome. Genomics 1991;10:201-210.
24. [24] Takao A, Ando M, Cho K, Kinouchi A, Murakami Y. Etiologic categorization of common congenital heart disease. In: Van Praagh R, Takao A, editors. Etiology and Morphogenesis of Congenital Heart Disease, New York:Futura, 1980:253-269.
25. [25] Momma K, Kondo C, Ando M, Matsuoka R, Takao A. Tetralogy of Fallot associated with chromosome 22q11 deletion. Am J Cardiol 1995;76:618-6-20.
26. [26] Lammer EJ, Opitz JM. The DiGeorge anomaly as a developmental field defect. Am J Med Genet I986;2(suppl):113-127.
27. [27] Sulik KK, Johnson MC, Daft PA, Russell WE, Dehart DB. Fetal alcohol syndrome and DiGeorge anomaly: Critical ethanol exposure periods for craniofacial malformations as illustrated in an animal model. Am J Med Genet 1986;2(suppl):97-112.
28. [28] Kirby ML, Waldo KL. Role of neural crest in congenital heart disease. Circulation 1990;82:332-340.
29. [29] Van Mierop LHS, Gessner IH. Pathogenetic mechanisms in congenital cardiovascular malformations. Prog Cardiovasc Dis 1972;15:67-85.
30. [30] Johnson MC. The neural crest in abnormalities of the face and brain. In: Bergsma D, editor. Morphogenesis and Malformation of Face and Brain. New York: Alan R. Liss, Inc., for the National Foundation-March of Dimes 1975;XI(7):1-18.
31. [31] Kirby ML, Gale TF, Stewart DE. Neural crest cells contribute to normal aortopulmonary septation. Science 1983;220:1059-1061.
32. [32] Kirby ML. Plasticity and pre-determination of mesencephalic and trunk neural crest transplanted into the region of the cardiac neural crest. Dev Biol 1989;134:401-412.
33. [33] Brockman DE, Redmond ME, Kirby ML. Alteration of early vascular development after ablation of cranial neural crest. Anatom Rec 1989;225:209-217.
34. [34] Levy A, Demczuk S, Aurias A, Depetris D, Mattel M-G, Philip N. Interstitial 22q11 microdeletion excluding the ADD breakpoint in a patient with DiGeorge syndrome. Hum Mol Genet 1995;4:2417-2419.
35. [35] Lindsay EA, Rizzu P, Antonacci R et al. A transcription map in the CATCH22 critical region: Identification, mapping and ordering of four novel transcripts expressed in heart. Genomics 1996;32:104-112.
36. [36] Lindsay EA, Halford S, Wadey R, Scambler PJ, Baldini A. Molecular cytogenetic characterization of the DiGeorge syndrome region using fluorescence in situ hybridization. Genomics 1993;17:403-407.
37. [37] Foster JW, Dominguez-Steglich MA, Guioli S et al. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 1994;372:525-530.
38. [38] Wagner T, Wirth J, Meyer J et al. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 1994;79:1111-1120.
39. [39] Halford S, Wilson DI, Roberts C et al. Isolation of a putative transcriptional regulator from the region of 22q11 deleted in DiGeorge syndrome, Shprintzen syndrome and familial heart disease. Hum Mol Genet 1993;2:2099-2107.
40. [40] Lamour V, Le'cluse Y, Desmaze C et al. A human homolog of the S. cerevisiae HIR1 and HIR2 transcription repressors cloned from the DiGeorge syndrome critical region. Hum Mol Genet 1995;4:791-799.
41. [41] Pizzuti A, Novelli G, Mari A et al. Human homolog sequences to the Drosophila dishevelled polarity gene are deleted in the DiGeorge syndrome. Am J Hum Genet 1996;58:722-729.
42. [42] Demczuk S, Aledo R, Zucman M et al. Cloning of a balanced translocation breakpoint in the DiGeorge syndrome critical region and isolation of a novel potential adhesion receptor gene in its vicinity. Hum Mol Genet 1995:4:551-558.
43. [43] Wadey R, Daw S, Taylor C et al. Isolation of a gene encoding an integral membrane protein from the vicinity of a balanced translocation breakpoint associated with DiGeorge syndrome. Hum Mol Genet 1995;4:1027-1033.
44. [44] Budarf ML, Collins J, Gong W et al. Cloning a balanced translocation asociated with DiGeorge syndrome and identification of a disrupted candidate gene. Nature Genet 1995;10:269-278.
45. [45] Demczuk S, Aurias A. DiGeorge syndrome and related syndromes associated with 22q11.2 deletions: A review. Ann Genet 1995;38:59-76.
46. [46] Rosenthal M, Bocian M, Krmpotic E. Multiple anomalies including thymic aplasia associated with monosomy 22. Pediatr Res 1972;6:358.
47. [47] Kelley RI, Zackai EH, Emanuel BS, Kistenmacher M, Greenberg F, Punnett HH. The association of the DiGeorge anomalad with partial monosomy of chromosome 22. J Pediatr 1982;101:197-200.
48. [48] Wilson DI, Cross IE, Goodship JA et al. A prospective cytogenetic study of 36 cases of DiGeorge syndrome. Am J Med Genet 1992;51:957-963.
49. [49] Carey AH, Kelley D, Halford S et al. Molecular genetic study of the frequency of monosomy 22q11 in DiGeorge syndrome. Am J Hum Genet 1992;51:964-970.
50. [50] Driscoll DD, Salvin J, Sellinger B et al. Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis. J Med Genet 1993;30:813-817.
51. [51] Ramirez-Solis R, Liu P, Bradley A. Chromosome engineering in mice. Nature 1995;378:720-724.